[1]
|
Xu F, Zhang Y, Chen Y. Cardiopulmonary resuscitation training in China: Current situation and future development[J]. JAMA Cardiol, 2017, 2: 469-470. doi: 10.1001/jamacardio.2017.0035 |
[2]
|
Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2022 update: A report from the American Heart Association[J]. Circulation, 2022, 145: e153-e639. |
[3]
|
Gräsner JT, Herlitz J, Tjelmeland IBM, et al. European Resuscitation Council guidelines 2021: Epidemiology of cardiac arrest in Europe[J]. Resuscitation, 2021, 161: 61-79. doi: 10.1016/j.resuscitation.2021.02.007 |
[4]
|
Johnson NJ, Caldwell E, Carlbom DJ, et al. The acute respiratory distress syndrome after out-of-hospital cardiac arrest: Incidence, risk factors, and outcomes[J]. Resuscitation, 2019, 135: 37-44. doi: 10.1016/j.resuscitation.2019.01.009 |
[5]
|
Ruwizhi N, Maseko RB, Aderibigbe BA. Recent advances in the therapeutic efficacy of artesunate[J]. Pharmaceutics, 2022, 14: 504. doi: 10.3390/pharmaceutics14030504 |
[6]
|
Lohani N, Rajeswari MR. Dichotomous life of DNA binding high mobility group box1 protein in human health and disease[J]. Curr Protein Pept Sci, 2016, 17: 762-775. doi: 10.2174/1389203717666160226145217 |
[7]
|
Xu J, Zhao X, Jiang X, et al. Tubastatin A improves post-resuscitation myocardial dysfunction by inhibiting NLRP3-mediated pyroptosis through enhancing transcription factor EB signaling[J]. J Am Heart Assoc, 2022, 11: e024205. doi: 10.1161/JAHA.121.024205 |
[8]
|
Sordi R, Nandra KK, Chiazza F, et al. Artesunate protects against the organ injury and dysfunction induced by severe hemorrhage and resuscitation[J]. Ann Surg, 2017, 265: 408-417. doi: 10.1097/SLA.0000000000001664 |
[9]
|
Khan AI, Kapoor A, Chen J, et al. The antimalarial drug artesunate attenuates cardiac injury in a rodent model of myocardial infarction[J]. Shock, 2018, 49: 675-681. doi: 10.1097/SHK.0000000000000963 |
[10]
|
Chen Y, Wu J, Zhu J, et al. Artesunate provides neuroprotection against cerebral ischemia-reperfusion injury via the TLR-4/NF-κB pathway in rats[J]. Biol Pharm Bull, 2021, 44: 350-356. doi: 10.1248/bpb.b20-00604 |
[11]
|
Ghoneim ME, Abdallah DM, Shebl AM, et al. The interrupted cross-talk of inflammatory and oxidative stress trajectories signifies the effect of artesunate against hepatic ischemia/reperfusion-induced inflammasomopathy[J]. Toxicol Appl Pharmacol, 2020, 409: 115309. doi: 10.1016/j.taap.2020.115309 |
[12]
|
Liu Z, Zhang J, Li S, et al. Artesunate inhibits renal ischemia reperfusion-stimulated lung inflammation in rats by activating HO-1 pathway[J]. Inflammation, 2018, 41: 114-121. doi: 10.1007/s10753-017-0669-3 |
[13]
|
Liu Z, Qu M, Yu L, et al. Artesunate inhibits renal ischemia-reperfusion-mediated remote lung inflammation through attenuating ROS-induced activation of NLRP3 inflammasome[J]. Inflammation, 2018, 41: 1546-1556. doi: 10.1007/s10753-018-0801-z |
[14]
|
Rosenthal PJ. Artesunate for the treatment of severe falciparum malaria[J]. N Engl J Med, 2008, 358: 1829-1836. doi: 10.1056/NEJMct0709050 |
[15]
|
Li Q, Cantilena LR, Leary KJ, et al. Pharmacokinetic profiles of artesunate after single intravenous doses at 0.5, 1, 2, 4, and 8 mg/kg in healthy volunteers: a phase I study[J]. Am J Trop Med Hyg, 2009, 81: 615-621. doi: 10.4269/ajtmh.2009.09-0150 |
[16]
|
谢娜, 范开亮, 邵旭鹏, 等. 调气利水汤治疗中度急性呼吸窘迫综合征患者的临床研究[J]. 中国中医急症, 2022, 31: 789-792. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJZ202205009.htm |
[17]
|
张汝敏, 王世富, 马爽, 等. PiCCO技术指导下不同呼气末正压水平对ARDS患者氧合的影响[J]. 中华急诊医学杂志, 2013, 22: 1398-1403. |
[18]
|
Wu H, Xu S, Diao M, et al. Alda-1 treatment alleviates lung injury after cardiac arrest and resuscitation in swine[J]. Shock, 2022, 58: 464-469. doi: 10.1097/SHK.0000000000002003 |
[19]
|
Wu C, Xu J, Jin X, et al. Effect of mild hypothermia on lung injury after cardiac arrest in swine based on lung ultrasound[J]. BMC Pulm Med, 2019, 19: 198. doi: 10.1186/s12890-019-0958-8 |
[20]
|
徐杰丰, 吴春双, 陈启江, 等. 经食道降温对猪复苏后肺损伤及全身性炎症反应的影响[J]. 华西医学, 2019, 34: 1261-1267. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYX201911009.htm |
[21]
|
原志芳, 孙鑫, 孟月, 等. 青蒿琥酯治疗重症疟疾随机对照试验的系统评价[J]. 中国循证医学杂志, 2007, 7: 794-801. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ200711011.htm |
[22]
|
Roberts BW, Kilgannon JH, Chansky ME, et al. Multiple organ dysfunction after return of spontaneous circulation in postcardiac arrest syndrome[J]. Crit Care Med, 2013, 41: 1492-1501. doi: 10.1097/CCM.0b013e31828a39e9 |
[23]
|
Adrie C, Adib-Conquy M, Laurent I, et al. Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome[J]. Circulation, 2002, 106: 562-568. doi: 10.1161/01.CIR.0000023891.80661.AD |
[24]
|
Wei J, Wang P, Li Y, et al. Inhibition of RHO kinase by fasudil attenuates ischemic lung injury after cardiac arrest in rats[J]. Shock, 2018, 50: 706-713. doi: 10.1097/SHK.0000000000001097 |
[25]
|
Wang Z, Wu L, Xu J, et al. Limb ischemic postconditioning alleviates postcardiac arrest syndrome through the inhibition of mitochondrial permeability transition pore opening in a porcine model[J]. Biomed Res Int, 2020, 2020: 9136097. http://pubmed.ncbi.nlm.nih.gov/32382579/ |
[26]
|
Shih CP, Kuo CY, Lin YY, et al. Inhibition of cochlear HMGB1 expression attenuates oxidative stress and inflammation in an experimental murine model of noise-induced hearing loss[J]. Cells, 2021, 10: 810. doi: 10.3390/cells10040810 |
[27]
|
Qiu C, Yang LD, Yu W, et al. Paeonol ameliorates CFA-induced inflammatory pain by inhibiting HMGB1/TLR4/NF-κB p65 pathway[J]. Metab Brain Dis, 2021, 36: 273-283. doi: 10.1007/s11011-020-00645-9 |
[28]
|
Shi X, Li M, Huang K, et al. HMGB1 binding heptamer peptide improves survival and ameliorates brain injury in rats after cardiac arrest and cardiopulmonary resuscitation[J]. Neuroscience, 2017, 360: 128-138. http://download.xuebalib.com/79ppvEMRrZC.pdf |
[29]
|
Sugita A, Kinoshita K, Sakurai A, et al. Systemic impact on secondary brain aggravation due to ischemia/reperfusion injury in post-cardiac arrest syndrome: a prospective observational study using high-mobility group box 1 protein[J]. Crit Care, 2017, 21: 247. doi: 10.1186/s13054-017-1828-5 |
[30]
|
Wang L, Li R, Guan X, et al. The value of extracellular cold-inducible RNA-binding protein (eCIRP) in predicting the severity and prognosis of patients after cardiac arrest: A preliminary observational study[J]. Shock, 2021, 56: 229-236. |
[31]
|
Hao D, Wang Y, Yang J, et al. The alleviation of LPS-induced murine acute lung injury by GSH-mediated PEGylated artesunate prodrugs[J]. Front Pharmacol, 2022, 13: 860492. |
[32]
|
Cui Y, Weng W, Ding Q, et al. The protective effect of artesunate on LPS-induced acute respiratory distress syndrome through inhibiting NLRP3 inflammasome signaling[J]. Evid Based Complement Alternat Med, 2022, 2022: 7655033. http://pubmed.ncbi.nlm.nih.gov/36051498/ |